Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy

Background: Randomized clinical trials have shown long-acting mono bronchodilator therapy to be efficacious in improving lung function and dyspnea, while reducing exacerbations; however, less is known regarding the effectiveness in routine clinical practice. This study examined treatment patterns, r...

Full description

Bibliographic Details
Main Authors:	Lindsay G.S. Bengtson, Michael DePietro, Jeffrey McPheeters, Kathleen M. Fox
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-05-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753466618772750

Similar Items

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
by: James F Donohue, et al.
Published: (2011-01-01)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
by: Kliber Agnes, et al.
Published: (2010-05-01)

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
by: Fujimoto K, et al.
Published: (2011-04-01)

Risk for cardiovascular events associated with long-acting inhaled bronchodilator in patients with chronic obstructive pulmonary disease
by: Hsiao-Chung Chao, et al.
Published: (2012)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
by: Strange C, et al.
Published: (2019-06-01)

Fixed dose long-acting bronchodilator combinations in chronic obstructive pulmonary disease: safety, effectiveness and cardiovascular system
by: I. V. Leshchenko
Published: (2018-10-01)

Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
by: Zoe A. Kopsaftis, et al.
Published: (2018-11-01)

Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
by: Meng-Ting Wang, et al.
Published: (2019-07-01)

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease
by: van der Vaart H, et al.
Published: (2011-04-01)

Dual bronchodilators in chronic obstructive pulmonary disease: Evidence from randomized controlled trials and real-world studies
by: Antonio Anzueto, et al.
Published: (2020-11-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease
by: S N Avdeev, et al.
Published: (2019-03-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

Salmeterol: a long acting bronchodilator.
by: Bhadoria D, et al.
Published: (1995-01-01)

Profiling the bronchodilator effects of the novel ultra-long-acting β-agonist indacaterol against established treatments in chronic obstructive pulmonary disease
by: Claus Vogelmeier, et al.
Published: (2011-10-01)

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
by: Ian Naya, et al.
Published: (2019-03-01)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
by: Asche CV, et al.
Published: (2012-03-01)

Risk of cardiovascular events after initiation of long-acting bronchodilators in patients with chronic obstructive lung disease: A population-based study
by: Almotasembellah Aljaafareh, et al.
Published: (2016-09-01)

Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response
by: Chiung-Zuei Chen, et al.
Published: (2011-11-01)

Comparison of Two Aerosolized Bronchodilators in the Treatment of Severe Equine Chronic Obstructive Pulmonary Disease
by: Friday, Philippa Anne
Published: (2011)

Bronchodilator Response in Airflow Obstruction after Treatment of Pulmonary TuberculosisA Retrospective Analysis
by: Marina Pires Nishi, et al.
Published: (2021-03-01)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
by: Melissa H. Roberts, et al.
Published: (2019-12-01)

Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
by: Rachael L DiSantostefano, et al.
Published: (2014-01-01)

Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping
by: Zhang X, et al.
Published: (2020-05-01)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01)

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
by: Pisi R, et al.
Published: (2015-06-01)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
by: Shih-Lung Cheng
Published: (2021-06-01)

Feasibility of testing bronchodilator responsiveness with glycopyrronium in obstructive airway diseases: the initial appraisal of the pilot experience
by: Parthasarathi Bhattacharyya, et al.
Published: (2021-01-01)

Bronchodilator reversibility test for broncho-obstructive syndrome detection and differential diagnosis of bronchial asthma and chronic obstructive pulmonary disease
by: V. P. Melnyk, et al.
Published: (2019-04-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015-03-01)

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review
by: Lopez-Campos JL, et al.
Published: (2017-06-01)

Advantage of impulse oscillometry over spirometry to diagnose chronic obstructive pulmonary disease and monitor pulmonary responses to bronchodilators: An observational study
by: Constantine Saadeh, et al.
Published: (2015-04-01)

Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
by: Yen-Fu Chen, et al.
Published: (2019-12-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-07-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-08-01)

Plagues, Public Health, and Politics
by: Jeffrey P. Koplan, et al.
Published: (2004-11-01)

Effectiveness and safety of bronchodilator use in chronic cardiac insufficiency of ischemic genesis comorbid with chronic obstructive pulmonary disease
by: Vladimir V. Evdokimov, et al.
Published: (2019-03-01)

Regional lung deflation with increased airway volume underlies the functional response to bronchodilators in chronic obstructive pulmonary disease
by: Naoya Tanabe, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_2f3i3mcl6je5ddmbnspiv1u0m5